Chemoinformaics analysis of 3,4-Dimethylbenzaldehyde
| Molecular Weight | 134.178 | nRot | 1 |
| Heavy Atom Molecular Weight | 124.098 | nRig | 23 |
| Exact Molecular Weight | 134.073 | nRing | 1 |
| Solubility: LogS | -4.529 | nHRing | 0 |
| Solubility: LogP | 3.985 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 20 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 1 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 9 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 6 |
| nHA | 1 | APOL | 22.4999 |
| nHD | 0 | BPOL | 10.9001 |
| QED | 0.581 |
| Synth | 5.215 |
| Natural Product Likeliness | 2.476 |
| NR-PPAR-gamma | 0.917 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.484 |
| Pgp-sub | 0.002 |
| HIA | 0.005 |
| CACO-2 | -4.775 |
| MDCK | 0.0000179 |
| BBB | 0.788 |
| PPB | 0.966513 |
| VDSS | 2.004 |
| FU | 0.0518093 |
| CYP1A2-inh | 0.025 |
| CYP1A2-sub | 0.205 |
| CYP2c19-inh | 0.015 |
| CYP2c19-sub | 0.884 |
| CYP2c9-inh | 0.232 |
| CYP2c9-sub | 0.581 |
| CYP2d6-inh | 0.013 |
| CYP2d6-sub | 0.472 |
| CYP3a4-inh | 0.058 |
| CYP3a4-sub | 0.241 |
| CL | 11.168 |
| T12 | 0.094 |
| hERG | 0.007 |
| Ames | 0.023 |
| ROA | 0.769 |
| SkinSen | 0.228 |
| Carcinogencity | 0.048 |
| EI | 0.504 |
| Respiratory | 0.981 |
| NR-Aromatase | 0.918 |
| Antiviral | No |
| Prediction | 0.899329 |